Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01970254 · ClinicalTrials.gov registry record
Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 2,206
- Enrollment target
NCT01970254: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT01970254 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 2,206 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01970254 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 2,206 participants
- Enrollment target
Study Summary
This trial studies hepatitis B screening strategies of new cancer patients scheduled to undergo chemotherapy. Patients with cancer and hepatitis B virus infection are at risk of reactivation of infection after chemotherapy. Hepatitis B virus infection reactivation can be prevented by starting antivirals before chemotherapy in patients who are hepatitis B virus infection positive. Hepatitis B screening may help doctors prevent the reactivation of hepatitis B virus infection after chemotherapy.
Interventions
- OTHER Survey Administration
- OTHER Hepatitis B Screening
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,206 participants |
| Start Date | 2013-06-24 |
| Est. Completion | 2022-07-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01970254
The ClinicalTrials.gov registry entry for NCT01970254 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Survey Administration is the first listed.
NCT01970254 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01970254 about?
NCT01970254 is a clinical study titled "Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy". This trial studies hepatitis B screening strategies of new cancer patients scheduled to undergo chemotherapy. Patients with cancer and hepatitis B virus infection are at risk of reactivation of infection after chemotherapy. Hepatitis B virus infection reactivation can be prevented by starting antivi...
What is the current status of trial NCT01970254?
This trial is currently completed. The enrollment target is 2,206 participants. The study started on 2013-06-24. Estimated completion is 2022-07-19.
What interventions are being tested in trial NCT01970254?
The interventions under investigation include: Survey Administration (OTHER), Hepatitis B Screening (OTHER).
Who is sponsoring clinical trial NCT01970254?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.